The flu shot typically reduces your chance of getting sick by 30% to 50% in any given year, depending on how well the vaccine matches the strains circulating that season. Over the past decade, the CDC has measured overall vaccine effectiveness as low as 29% (2018–2019) and as high as 56% (2024–2025, preliminary). Those numbers might sound modest compared to vaccines for measles or tetanus, but they only tell part of the story. Even in a “bad” year, the flu shot substantially reduces hospitalizations, ICU admissions, and deaths.
Why Effectiveness Changes Every Year
Influenza viruses mutate constantly. Each year, researchers predict which strains will dominate and build a vaccine months in advance. When that prediction lines up with what actually circulates, the vaccine works well. When it doesn’t, protection drops sharply. A decade-long study covering 2011 through 2021 found that only three out of nine seasons had a strong antigenic match between the vaccine and circulating strains. In matched seasons, effectiveness averaged about 29%. In mismatched seasons, it dropped to essentially zero.
The 2025–2026 flu vaccines are trivalent, meaning they target three viruses: an H1N1 strain, an H3N2 strain, and a B/Victoria lineage strain. H3N2 seasons tend to be tougher because that virus mutates faster, making it harder to match. H1N1-dominant seasons generally produce better vaccine performance.
Protection Against Hospitalization and Death
Raw effectiveness numbers measure whether you get sick at all. The vaccine’s performance against serious outcomes is consistently stronger. During the 2024–2025 season, vaccination reduced flu-related hospitalizations by 41% to 55% in adults overall. For children and adolescents, the numbers were even better: 63% to 78% reduction in hospitalizations across two monitoring networks.
If you do get the flu despite being vaccinated, your illness is likely to be less severe. Studies of breakthrough infections show that vaccinated people have lower viral loads, shorter illness duration, and fewer febrile symptoms. Among children who caught the flu after vaccination, the odds of developing a fever dropped by 45%. Among hospitalized adults, vaccinated patients had a 26% lower chance of needing ICU care and a 31% lower risk of dying compared to unvaccinated patients with the same diagnosis.
For children specifically, vaccination cuts flu-related mortality roughly in half among those considered high-risk.
How Quickly Protection Fades
Flu shot protection doesn’t last the entire season at full strength. An analysis covering nine pre-COVID flu seasons in Ontario found that effectiveness in adults drops by about 9% every 28 days, starting around six weeks after vaccination. That waning was most pronounced in adults 18 to 64 against H1N1 and in adults 65 and older against H3N2.
This is why timing matters. If you get vaccinated in early September and flu activity doesn’t peak until February, you may have lost several months of protection by the time you need it most. For most people, late September through October hits the sweet spot, giving your body about two weeks to build immunity while preserving reasonable protection through the winter months. Children did not show the same rate of waning in this analysis.
Effectiveness for Older Adults
Adults 65 and older face a double problem: they’re more likely to be hospitalized or die from influenza, and their immune systems respond less vigorously to standard vaccines. During the 2024–2025 season, outpatient effectiveness for this age group was about 51%, and hospitalization prevention ranged from 38% to 57% depending on the monitoring network.
To compensate for age-related immune decline, the CDC preferentially recommends higher-dose or adjuvanted flu vaccines for people 65 and older rather than the standard-dose version. These formulations contain either more of the active ingredient or an additive that boosts the immune response. The recommendation is based on evidence that these enhanced vaccines are more effective than standard doses in this age group. If you’re 65 or older, it’s worth confirming with your pharmacist that you’re receiving one of these versions rather than the regular shot.
Benefits Beyond Preventing the Flu
One of the most underappreciated effects of flu vaccination is cardiovascular protection. Influenza triggers systemic inflammation that can destabilize arterial plaques, raising the risk of heart attacks and strokes in the weeks following infection. A meta-analysis pooling 63 studies found that flu vaccination was associated with a 26% reduction in cardiovascular events, including stroke, heart attack, acute coronary syndrome, and heart failure. For people with existing heart disease, the flu shot functions almost like a seasonal cardiac intervention.
What 40% Effectiveness Actually Means
A 40% effectiveness rate sounds unimpressive until you consider the scale. Tens of millions of Americans get the flu each year. A vaccine that prevents 40% of those cases eliminates millions of infections, hundreds of thousands of medical visits, and thousands of hospitalizations in a single season. The CDC has estimated that flu vaccination prevented approximately 6 million illnesses in some recent seasons.
It also helps to compare the flu shot to other common health interventions. Seatbelts reduce the risk of fatal injury by about 45%. No one considers that number a reason to stop wearing one. The flu shot works on a similar principle: imperfect protection that, applied across an entire population, saves a large number of lives. And if you do get infected after vaccination, you’re looking at milder symptoms, fewer days of illness, and a meaningfully lower chance of ending up in the hospital.